Low grade serous ovarian cancer: Unpicking drivers of outcome

Gynecol Oncol. 2022 Nov;167(2):137-138. doi: 10.1016/j.ygyno.2022.10.007.

Authors

Charlie Gourley¹, Robert L Hollis²

Affiliations

¹ Nicola Murray Centre for Ovarian Cancer Research, CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, UK. Electronic address: charlie.gourley@ed.ac.uk.
² Nicola Murray Centre for Ovarian Cancer Research, CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, UK.

PMID: 37850592
DOI: 10.1016/j.ygyno.2022.10.007

No abstract available

Publication types

Editorial

MeSH terms

Cystadenocarcinoma, Serous*
Female
Humans
Ovarian Neoplasms* / therapy